> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Comments Extended on Quality Metrics Guidance
- URL: https://www.fdaweb.com/comments-extended-on-quality-metrics-guidance/
- Published: 2017-01-09T12:00:00.000Z
- Updated: 2026-09-14T21:58:46.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5137663

*Federal Register* Notice: FDA has extended the comment period for a revised draft guidance entitled “Submission of Quality Metrics Data” that was published in the 11/25/2016 *Federal Register*. The document describes FDA’s plans for an initial, voluntary phase of its quality metrics program that will allow the agency to learn more about a limited set of quality metrics and associated analytics. This revised draft also provides an opportunity to gain additional perspectives from industry participants on the future use of quality metrics data. Comments will be accepted until 3/27\. To view the guidance, click [here](http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM455957.pdf?ref=fdaweb.com). To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-01-09/pdf/2017-00094.pdf?ref=fdaweb.com).